Counting the number of tumor cells circulating in the bloodstream of patients with castration-resistant prostate cancer can accurately predict how well they are responding to treatment, new results show.
Researchers showed that changes in the number of circulating tumor cells predicted the outcome after chemotherapy in this hard to treat cancer.
circulating tumor cellsCounting Tumor Cells In Blood Predicts Treatment Benefit In Pros...ScienceDaily Mon, 07/07/2008 - 13:00
Circulating Tumor Cells Can Reveal Genetic Signature Of Dangerou...ScienceDaily Thu, 07/03/2008 - 16:45
A microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy. |
